Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
News or just a lot of talk?
Toni said in the interview he's putting out news tomorrow / today as it just turned midnight.
Just put out a press release when you actually DO something, Tony. To date, you haven't accomplished anything meaningful.
$BMCS Good interview.
BMCS upcoming updates based on PRs
1. Already filed for QB tier and waiting for reflect this higher tier change. Expecting very soon
2. After QB status changed and waiting for company to apply for QX higher tier which needs $1 PPs and they already have $35M assets.
Interview with Tony Miller and find out more about USEI will be crypto
Mining and BMCS will be QX very soon.
Usei share buy back will be huge
Watch what happens to BMCS when he puts out news saying he finished raising 10 M .. That's not much money with the players he knows... USEI will do well too. Keep an on DIGAF .0040 + it will breakout..
It's been a month and a half since Miller supposedly applied to OTC Markets for the OTCQB designation. Maybe he forgot to send the check for $14,000 because Coulson would want that money in his account as fast as possible.
Bmcs already filed to uplist on QB tier and after they will uplist on OtcQC tier which will lead the pps in dollars
Stay tuned
Buy and hold
Float is tiny
Share structure is so small
AS is 500M shares with 200M OS
Float is near 38 M
Why Monday in particular? Also, why any day soon? They have not said anything of import in a while. Stock action not evidencing anything imminent—in fact the opposite.
Monday is good time for interview
Bmcs and USEI will be huge
That's a barebones filing.
Total offering amount is $0?
Good luck raising $10M, Tony.
Management intends to utilize its own contacts to raise its funds from its contacts
They filed a Form D Exempt Offering
Offering amount is Zero
But Use of Proceeds is $10,000,000
Would have expected more than just 4,500 volume with news finally coming out.
Miller has the capital to acquire $40m in assets but needs to raise money to start a business.
Today we are launching our company's website that provides information on this new direction of our firm. We are continuously accumulating assets under management which now total over $40 million and our assets under consignment are extremely significant. BMCS has a tremendous business model that is patterned after other companies in this Digital Asset Marketplace. Our goal is to make Sumcoin as liquid as other currencies in this digital ecosystem. We have also filed a Reg D 506c with the SEC and will immediately begin to raise capital with this exemption to develop our business model and build assets and share value for our investors and add Sumcoin on as many exchanges as necessary for awareness and liquidity.
$BMCS BMCS Launches Its New Website and Announces a New Direction for the Firm
Press Release | 11/29/2021
WOODLAND HILLS, CA / ACCESSWIRE / November 29, 2021 / BMCS SUMCOIN INDEX FUND, INC doing business as BioTech Medics, Inc stock symbol BMCS is still awaiting the announcement of the name change, is pleased to launch its new website (www.bmcssumcoin.com) and business plan in the digital asset marketplace.
According to Anthony K. Miller, CEO, "for months our company has been anticipating these events that are announced today, and it is now time to move toward with our mission to enter the digital asset sector. To date we have built our Delaware Statutory Trust, built the Architecture of our Business Plan, and built an Incredible Team (that will continue to grow) to move us into this new chapter of this company's history. Today we are launching our company's website that provides information on this new direction of our firm. We are continuously accumulating assets under management which now total over $40 million and our assets under consignment are extremely significant. BMCS has a tremendous business model that is patterned after other companies in this Digital Asset Marketplace. Our goal is to make Sumcoin as liquid as other currencies in this digital ecosystem. We have also filed a Reg D 506c with the SEC and will immediately begin to raise capital with this exemption to develop our business model and build assets and share value for our investors and add Sumcoin on as many exchanges as necessary for awareness and liquidity.
Our business plan provides investors with the ability to participate in this industry by investing in common stock representing one currency: Sumcoin (the world's first index coin). Sumcoin is a cryptographic blockchain using scrypt proof-of-work algorithm. Sumcoin tracks all digital coins in real-time and its price is an aggregate or "SUM" of all top 100 coins most valuable coins by market capitalization. Our plan is to provide a solution for those who want to gain maximum exposure into the digital space (without having to learn the complexities of this new industry) but only want to hold "one digital asset" for simplicity, we believe that the BMCS Sumcoin Index Fund is that solution.
Today we begin a soft launch of our business plan and in the coming weeks we will have a more robust project launch to a broader audience. I invite you all to visit our website at www.bmcssumcoin.com to better understand our mission and business model; commented Miller"
READ MORE ABOUT SUMCOIN: https://www.sumcoin.org/
About BMCS SUMCOIN INDEX FUND/ BioTech Medics, Inc a publicly traded Wyoming company traded on the OTC Markets under the stock symbol BMCS-OTC located in Los Angeles California. BMCS has historically been a biotech firm however, now a "Digital Asset Firm" focusing on Sumcoin (the world's first indexed currency) one of the most significant currencies in the world.
Forward-Looking Statements: This press release contains "forward-looking statements" within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. All statements, other than statements of historical fact, including those with respect to the expected projects of BioTech Medics, Inc., and related companies. All statements that are included in this Press release, other than statements of historical fact, are forward-looking statements. Forward-looking statements involve known and unknown risks, assumptions, uncertainties, and other factors. Statements made in the future tense, and statements using-words-such as "may, "can," "could," "should," "predict," "aim'" "potential," "continue," "opportunity," "intend " "goal," "estimate," "expect," "expectations," "project," "projections," "plans," "anticipates," "believe," "think," "confident" "scheduled" or similar expressions are intended to identify forward-looking statements. Forward-looking statements are not a guarantee of performance and are subject to a number of risks and uncertainties, many of which are difficult to predict and are beyond our control.
These risks and uncertainties could cause actual results to differ materially from those expressed in or implied by the forward-looking statements, and therefore should be carefully considered. You should consider the areas of risk described in connection with any forward-looking statements that may be made herein. We caution you not to place undue reliance on the forward-looking statements, which speak only as of the date of this report and readers should carefully review this report in its entirety. We disclaim any obligation to update any of these forward-looking statements as a result of new information, future events, or otherwise, except as expressly required by law. Further information on our risk factors is contained in our filings with the OTC Markets and the SEC website. Any forward-looking statement made by us herein speaks only as of the date on which it is made. Factors or events that could cause our actual results to differ may emerge from time to time, and it is not possible for us to predict all of them. We undertake no obligation to publicly update any forward-looking statement, whether as a result of new information, future developments or otherwise, except as may be required by law.
CONTACT INFORMATION
INVESTOR RELATIONS
STOCK SYMBOL: (BMCS-OTC)
EMAIL: tony@biotecmedics.com
WEBSITE: www.bmcssumcoin.com
PHONE: 800.988.3782
LOCATION: WOODLAND HILLS, CA.
SOURCE: BioTech Medics Inc/BMCS SUMCOIN INDEX FUND
View source version on accesswire.com:
https://www.accesswire.com/674952/BMCS-Launches-Its-New-Website-and-Announces-a-New-Direction-for-the-Firm
The whole industry is messed up, if you ask me.
Thanks for the bucket of cold water. The world is back in equilibrium
Wake up! You are most definitely dreaming.
Unfolding stories aren't always positive. Think Nightmare on Elm Street.
Do I detect a slight note of positivity, or am I dreaming??
It's a story that's yet to unfold. What will be revealed should be interesting.
Probably the only other entity that has Sumcoin is USEI, I would think
Q3 report is out.
https://www.otcmarkets.com/otcapi/company/financial-report/311048/content
During the period ended September 30, 2021, the Company has issued Series A preferred shares to certain shareholders for $10,000 in cash to be used as working capital. Additionally, the Company also issued 20,000 Series A Preferred shares for $30 Million dollars of Sumcoin Digital Assets (39,370 coin) that are reflected on the Company’s Balance Sheet as Digital Assets (currency).
Interesting. The inferred price of a Series A Preferred shares for the Sumcoins is $1500. Yet, the inferred price for $10,000 in working capital is just $16.67, since only 600 shares were issued in exchange.
It would seem that the carrying value of the Sumcoins is inflated.
And from whom were they acquired?
$BMCS BioTech Medics, Inc. Provides a Company Update as The Firm Anticipates Its Name Change To Become Approved
Press Release | 11/08/2021
WOODLAND HILLS, CA / ACCESSWIRE / November 8, 2021 / BioTech Medics, Inc. (OTC PINK:BMCS) announces that the Company continues to cooperate with FINRA to effectuate the Company's name change from Bio Tech Medics to BMCS Sumcoin Index Fund Inc.
According to Anthony K. Miller, CEO, Management continues to reply to every regulatory inquiry with hopes this name change will be effective immediately. Over the past 2 months there has been minimal to no additional question regarding this corporate action, and Management is in contact daily with FINRA anticipating that this is the day when it will become the effective date. BMCS has been under an extensive micro review for over a couple months primarily because of the Digital Asset industry is under significant review by this regulatory agency. Once this name change is approved Management will begin a significant "project launch and awareness campaign" to provide the financial and investor community with our new business blueprint. Over 2 months ago, we finalized our new website that provides detailed information on this new direction, and that site will become live once the name change is effective. We have also built a knowledgeable team of professionals that understand digital markets and the intersection of this currency cross markets; now totalling 15 knowledgeable staff members. BMCS has a tremendous business model that is patterned after other companies in this Digital Asset space and Management has been actively accumulating significant Sumcoin from multiple sources that will be utilized to execute our business plan and to increase our NAV from what we last reported. We are excited about our potential earning power and last week management filed an application with OTC Markets to move BMCS to the OTCQB tier with the hope that we can move to OTCQX in 2022. Management appreciates the patience of its investors and hopeful that after we get to our project launched, the trajectory of our venture will be significantly positive and lucrative. Our goal is to make Sumcoin as liquid as other currencies in this our digital ecosystem; commented Miller"
READ MORE ABOUT SUMCOIN: https://www.sumcoin.org/
About BioTech Medics, Inc.: BioTech Medics, Inc is a publicly traded Wyoming company traded on the OTC Markets under the stock symbol BMCS located in Los Angeles California. BioTech Medics Inc. has historically been a biotech firm however, now a "Digital Asset Firm" focusing on Sumcoin (the world's first indexed currency) one of the most significant currencies in the world.
Forward-Looking Statements: This press release contains "forward-looking statements" within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. All statements, other than statements of historical fact, including those with respect to the expected projects of BioTech Medics, Inc., and related companies. All statements that are included in this Press release, other than statements of historical fact, are forward-looking statements. Forward-looking statements involve known and unknown risks, assumptions, uncertainties, and other factors. Statements made in the future tense, and statements using-words-such as "may, "can," "could," "should," "predict," "aim'" "potential," "continue," "opportunity," "intend " "goal," "estimate," "expect," "expectations," "project," "projections," "plans," "anticipates," "believe," "think," "confident" "scheduled" or similar expressions are intended to identify forward-looking statements. Forward-looking statements are not a guarantee of performance and are subject to a number of risks and uncertainties, many of which are difficult to predict and are beyond our control.
These risks and uncertainties could cause actual results to differ materially from those expressed in or implied by the forward-looking statements, and therefore should be carefully considered. You should consider the areas of risk described in connection with any forward-looking statements that may be made herein. We caution you not to place undue reliance on the forward-looking statements, which speak only as of the date of this report and readers should carefully review this report in its entirety. We disclaim any obligation to update any of these forward-looking statements as a result of new information, future events, or otherwise, except as expressly required by law. Further information on our risk factors is contained in our filings with the OTC Markets and the SEC website. Any forward-looking statement made by us herein speaks only as of the date on which it is made. Factors or events that could cause our actual results to differ may emerge from time to time, and it is not possible for us to predict all of them. We undertake no obligation to publicly update any forward-looking statement, whether as a result of new information, future developments or otherwise, except as may be required by law.
CONTACT INFORMATION
INVESTOR RELATIONS
STOCK SYMBOL: (BMCS-OTC)
EMAIL: tony@biotecmedics.com
WEBSITE: www.biotecmedics.com
PHONE: 800.988.3782
LOCATION: WOODLAND HILLS, CA.
SOURCE: BioTech Medics Inc
View source version on accesswire.com:
https://www.accesswire.com/671601/BioTech-Medics-Inc-Provides-a-Company-Update-as-The-Firm-Anticipates-Its-Name-Change-To-Become-Approved
Or do they have a problem with Miller?
https://twitter.com/freeotcupdates/status/1457749676057321477
BMCS couldn’t sell hand sanitizer during a world wide viral pandemic. Is it any wonder few are buying their latest crypto index fund fantasy? Fear not, when this new adventure fails I’m sure they will change their name yet again to BMCS Flex Seal.
$BMCS BioTech Medics, Inc. Provides a Company Update as The Firm Anticipates Its Name Change To Become Approved
Press Release | 11/08/2021
WOODLAND HILLS, CA / ACCESSWIRE / November 8, 2021 / BioTech Medics, Inc. (OTC PINK:BMCS) announces that the Company continues to cooperate with FINRA to effectuate the Company's name change from Bio Tech Medics to BMCS Sumcoin Index Fund Inc.
According to Anthony K. Miller, CEO, Management continues to reply to every regulatory inquiry with hopes this name change will be effective immediately. Over the past 2 months there has been minimal to no additional question regarding this corporate action, and Management is in contact daily with FINRA anticipating that this is the day when it will become the effective date. BMCS has been under an extensive micro review for over a couple months primarily because of the Digital Asset industry is under significant review by this regulatory agency. Once this name change is approved Management will begin a significant "project launch and awareness campaign" to provide the financial and investor community with our new business blueprint. Over 2 months ago, we finalized our new website that provides detailed information on this new direction, and that site will become live once the name change is effective. We have also built a knowledgeable team of professionals that understand digital markets and the intersection of this currency cross markets; now totalling 15 knowledgeable staff members. BMCS has a tremendous business model that is patterned after other companies in this Digital Asset space and Management has been actively accumulating significant Sumcoin from multiple sources that will be utilized to execute our business plan and to increase our NAV from what we last reported. We are excited about our potential earning power and last week management filed an application with OTC Markets to move BMCS to the OTCQB tier with the hope that we can move to OTCQX in 2022. Management appreciates the patience of its investors and hopeful that after we get to our project launched, the trajectory of our venture will be significantly positive and lucrative. Our goal is to make Sumcoin as liquid as other currencies in this our digital ecosystem; commented Miller"
READ MORE ABOUT SUMCOIN: https://www.sumcoin.org/
About BioTech Medics, Inc.: BioTech Medics, Inc is a publicly traded Wyoming company traded on the OTC Markets under the stock symbol BMCS located in Los Angeles California. BioTech Medics Inc. has historically been a biotech firm however, now a "Digital Asset Firm" focusing on Sumcoin (the world's first indexed currency) one of the most significant currencies in the world.
Forward-Looking Statements: This press release contains "forward-looking statements" within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. All statements, other than statements of historical fact, including those with respect to the expected projects of BioTech Medics, Inc., and related companies. All statements that are included in this Press release, other than statements of historical fact, are forward-looking statements. Forward-looking statements involve known and unknown risks, assumptions, uncertainties, and other factors. Statements made in the future tense, and statements using-words-such as "may, "can," "could," "should," "predict," "aim'" "potential," "continue," "opportunity," "intend " "goal," "estimate," "expect," "expectations," "project," "projections," "plans," "anticipates," "believe," "think," "confident" "scheduled" or similar expressions are intended to identify forward-looking statements. Forward-looking statements are not a guarantee of performance and are subject to a number of risks and uncertainties, many of which are difficult to predict and are beyond our control.
These risks and uncertainties could cause actual results to differ materially from those expressed in or implied by the forward-looking statements, and therefore should be carefully considered. You should consider the areas of risk described in connection with any forward-looking statements that may be made herein. We caution you not to place undue reliance on the forward-looking statements, which speak only as of the date of this report and readers should carefully review this report in its entirety. We disclaim any obligation to update any of these forward-looking statements as a result of new information, future events, or otherwise, except as expressly required by law. Further information on our risk factors is contained in our filings with the OTC Markets and the SEC website. Any forward-looking statement made by us herein speaks only as of the date on which it is made. Factors or events that could cause our actual results to differ may emerge from time to time, and it is not possible for us to predict all of them. We undertake no obligation to publicly update any forward-looking statement, whether as a result of new information, future developments or otherwise, except as may be required by law.
CONTACT INFORMATION
INVESTOR RELATIONS
STOCK SYMBOL: (BMCS-OTC)
EMAIL: tony@biotecmedics.com
WEBSITE: www.biotecmedics.com
PHONE: 800.988.3782
LOCATION: WOODLAND HILLS, CA.
SOURCE: BioTech Medics Inc
View source version on accesswire.com:
https://www.accesswire.com/671601/BioTech-Medics-Inc-Provides-a-Company-Update-as-The-Firm-Anticipates-Its-Name-Change-To-Become-Approved
I wonder if Finra has a problem with Sumcoin.
BioTech Medics, Inc. Provides a Company Update as The Firm Anticipates Its Name Change To Become Approved
Press Release | 11/08/2021
WOODLAND HILLS, CA / ACCESSWIRE / November 8, 2021 / BioTech Medics, Inc. (OTC PINK:BMCS) announces that the Company continues to cooperate with FINRA to effectuate the Company's name change from Bio Tech Medics to BMCS Sumcoin Index Fund Inc.
According to Anthony K. Miller, CEO, Management continues to reply to every regulatory inquiry with hopes this name change will be effective immediately. Over the past 2 months there has been minimal to no additional question regarding this corporate action, and Management is in contact daily with FINRA anticipating that this is the day when it will become the effective date. BMCS has been under an extensive micro review for over a couple months primarily because of the Digital Asset industry is under significant review by this regulatory agency. Once this name change is approved Management will begin a significant "project launch and awareness campaign" to provide the financial and investor community with our new business blueprint. Over 2 months ago, we finalized our new website that provides detailed information on this new direction, and that site will become live once the name change is effective. We have also built a knowledgeable team of professionals that understand digital markets and the intersection of this currency cross markets; now totalling 15 knowledgeable staff members. BMCS has a tremendous business model that is patterned after other companies in this Digital Asset space and Management has been actively accumulating significant Sumcoin from multiple sources that will be utilized to execute our business plan and to increase our NAV from what we last reported. We are excited about our potential earning power and last week management filed an application with OTC Markets to move BMCS to the OTCQB tier with the hope that we can move to OTCQX in 2022. Management appreciates the patience of its investors and hopeful that after we get to our project launched, the trajectory of our venture will be significantly positive and lucrative. Our goal is to make Sumcoin as liquid as other currencies in this our digital ecosystem; commented Miller"
Tweet
BMCS Sumcoin
@BMCSSumcoin
Some $BMCS news coming on Monday
3:38 PM · Nov 4, 2021
US Energy Initiatives Provides an Update on Its Potential Projects
https://www.globenewswire.com/news-release/2021/11/02/2325479/0/en/US-Energy-Initiatives-Provides-an-Update-on-Its-Potential-Projects.html
US Energy Initiatives Corp, Inc. (OTC PINK:USEI) announces that Management is still investigating 2 business ventures that will bring significant shareholder value to the stockholders of the company.
According to Anthony K. Miller, CEO, "With the rapidly changing Digital Assets landscape, Management is working on closing opportunities that are before us. Currently, the company’s digitals assets hover between $50- $60 Million dollars (significantly more than we last noted). It is Management’s goal to make the best decisions possible, and we have delayed utilizing these assets because of the rapidly appreciating value they possess. The goal is to pledge or sell a portion of this currency to capitalize on these opportunities. We just don’t want to make a deal just to make folks happy, we want an awesome deal. It is our intent to have great news to report in the next couple weeks, more significant than this update.
“As Sumcoin continually reaches historical values (over $1200.00)… and with the approval of our related firm by the regulators, USEI could possibly sell its assets at the full market value, instead of discounting the price, which is a far better option to us all.
“Finally, we continue to reiterate that will not increase the authorized shares of the Company and there is no reverse split contemplated for the present or the future. The fundamentals of this firm are fixed and changing this structure is not in anyone’s best interest. It is still Management’s belief that this company will create significant strategic alliances in the coming months,” stated Miller.
Tweet
US Energy Initiatives
@USEnergyInit
·
5h
IN CASE YOU DIDN'T KNOW... #SUMCOIN REMAINS IN THE $1200.00 RANGE WHICH INCREASES OUR HOLDING IN THE $50-$60,000,000 RANGE. WE WILL NEVER INCREASE $USEI STOCK AUTHORIZED AND NO R/S EVER... WE CONTINUE TO WAIT ON THE NAME CHANGE OF $BMCS AND CONTINUE TO WORK ON OPPORTUNITIES
Large ask at .0596 535,700
If it gets taken out, then there is some hope
Have you ever read a truly audited 10-K from an SEC reporting company? BMCS is alternative filing and reporting under OTC Pink Basic Disclosure Guidelines.
As to $30M in assets, I'm looking at page 11 of 12. It shows $382 of total assets.
Shhhh let’s not talk about the Audited financials showing 30 million in Assets GLTY
No, they're not. There has never been a short position in BMCS that would affect the sp. The last report shows a short interest of just 631.
Shorts are playing very hard
A rose by other name ......
Or, in this case a skunk cabbage.
Finra name change is due
Let’s see when finra complete the process
I guess it's to be expected when a serial failure touts his latest money making scheme but doesn't follow through with any signs of success for months.
More than half millions shares sold at bid
Sinking now
Actually has a normal bid now at .058
After dropping 99% the day before.
And 50% lower than where it's been trading the past three months.
Putting lipstick on a pig.
Fourth time this year.
DATE SYMBOL COMPANY NAME OLD TIER NEW TIER SECURITY TYPE
10/13/2021 Pink Open Market LogoBMCS BioTech Medics, Inc. Pink Limited Pink Current Common Stock
08/23/2021 Pink Open Market LogoBMCS BioTech Medics, Inc. Pink Current Pink Limited Common Stock
07/14/2021 Pink Open Market LogoBMCS BioTech Medics, Inc. Pink Limited Pink Current Common Stock
05/19/2021 Pink Open Market LogoBMCS BioTech Medics, Inc. Pink Current Pink Limited Common Stock
BMCS up 20,700.00% today.
And it only took $10 to do it.
I wonder if that was a commission free trade.
because its a scam?? who knew
BIO TECH MEDICS, INC
Website : https://biotecmedics.com/
Secretary of State Fillings: https://wyobiz.wyo.gov/Business/FilingDetails.aspx?eFNum=132046134203116122036072205240213042155033063041
Twitter link Posts with replies by anthony miller (@anthony88205118) / X (twitter.com)
Over the past two years we focused most of our efforts as a digital asset business and as a result faced significant opposition in the regulatory environment, as a result of this the management has decided to shift its assets and energy back the origins of the firm, the biotech sector as our path. Management has also abandoned its name change to BMCS Sumcoin Index Fund, retaining our current name. Note BMCS still maintains significant digital assets and management is currently in negotiations to utilize those assets to enhance our new vision.
BIO TECH MEDICS, INC
1. $BMCS is current now https://www.otcmarkets.com/stock/BMCS/overview ;
2. $BMCS Attorney Letter https://www.otcmarkets.com/otcapi/company/financial-report/382689/content ;
3. $BMCS Company Website
https://biotechmedics.co ;
4. $BMCS Twitter Link
https://twitter.com/biotecmedics?s=21&t=y7yrqIlNM3fsfWkjz_Q1IQ ;
5. $BMCS Secretary Of State Link
https://wyobiz.wyo.gov/Business/FilingDetails.aspxeFNum=132046134203116122036072205240213042155033063041 ;
6. $BMCS CEO Twitter Link: https://twitter.com/anthony88205118?s=21&t=y7yrqIlNM3fsfWkjz_Q1IQ
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |